Yonseisarangmoa women disease hospital
Yonseisarangmoa women disease hospital
Republic of Korea, Seoul
Go Mi Hyang
25 years of experience
Clinic is certified :
In the Republic of Korea, IVF with gender selection typically ranges from AUD $14,609 to AUD $24,062. The total cost depends on clinic location, medication requirements, and genetic testing protocols. In Australia, this procedure averages AUD $21,484, allowing patients to save approximately 32%. This treatment usually includes consultations, egg retrieval, hormonal stimulation, and embryo transfer for medical reasons.
Bookimed Expert Insight: Choosing a Seoul-based medical hub provides access to highly specialised clinicians. For instance, Yonseisarangmoa Women’s Hospital uses advanced technology and treats over 4,500 patients annually. While Seoul prices are higher, specialists like Dr. Hong Jung Lee offer unique expertise in complex reproductive surgery. Patients benefit from centres that integrate obstetrics and fetal medicine into a single specialized facility.
| Republic of Korea | Thailand | Turkey | |
| IVF with Gender Selection | from AUD $14,609 | from AUD $18,780 | from AUD $9,310 |
No hidden fees – just official clinic prices. Pay at the clinic for IVF with Gender Selection upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in IVF with Gender Selection and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your IVF with Gender Selection journey.
Dr. Hong Ju is a reproductive endocrinologist at Yonsei Sarangmoa Women’s Hospital in Seoul. He is the Co-Director of the hospital and an adjunct professor at Yonsei University. Dr. Ju specializes in infertility treatments, sexology, and urogynecology. He works at a facility where over 10,000 babies have been born.
Dr. Hong Jung Lee is the director of Yonsei Sarangmoa Women’s Hospital in Seoul. He is recognized as a pioneer in robotic gynecological surgery in South Korea. Dr. Lee performs procedures using the da Vinci Surgical System. He specializes in reproductive endocrinology, infertility treatments, and complex gynecological oncology.
Professor An Jea Hyeong serves as an Adjunct Professor at Inje University Paik Hospital, specialising in high-standard fertility and obstetric care.
Elective gender selection for IVF is illegal in the Republic of Korea. The Bioethics and Safety Act strictly prohibits choosing a child's sex for non-medical reasons. Specialists only perform gender selection to prevent severe sex-linked genetic disorders through preimplantation genetic testing.
Bookimed Expert Insight: While elective selection is banned, South Korean clinics excel in health-focused screening. Facilities like Yonseisarangmoa Hospital have supported over 10,000 successful births. Dr Hong Jung Lee and Dr Hong Ju use genetic testing for aneuploidy. This maximises pregnancy success rates for older patients.
Patient Consensus: Couples must be legally married to access any IVF services in South Korea. Patients find PGT useful for screening health risks like trisomy. However, gender selection remains restricted.
Gender selection in the Republic of Korea achieves 99% accuracy when performed using Preimplantation Genetic Testing (PGT). However, South Korean law strictly prohibits disclosing embryo sex for non-medical reasons. This service is exclusively reserved for families at risk of passing on hereditary sex-linked genetic disorders.
Bookimed Expert Insight: While South Korean clinics like Yonseisarangmoa women disease hospital have high success rates, Australians seeking elective gender selection should look elsewhere. Data suggests Northern Cyprus or Mexico as viable alternatives where disclosure is legally permitted for family balancing.
Patient Consensus: Patients find that Korean clinics are efficient and affordable for standard IVF. However, those specifically wanting to choose gender often travel to other countries due to strict local laws.
Success rates for gender selection in the Republic of Korea depend heavily on maternal age. Genetic testing remains nearly 100% accurate for sex identification. However, the probability of producing a chromosomally normal embryo of the desired gender declines significantly. This decline happens as women age, especially after 40.
Bookimed Expert Insight: Data shows that Yonseisarangmoa Women’s Hospital in Seoul has helped deliver 10,000+ babies. Their specialists, like Dr Hong Ju, use genetic testing for aneuploidy. Success for older patients often hinges on these precise screenings rather than the gender selection itself.
Patient Consensus: Getting enough embryos for selection is difficult for women over 40 in South Korea. Patients often need several treatment cycles to find a healthy embryo of their preferred sex.
Determining embryo gender in South Korea is only possible through Preimplantation Genetic Testing (PGT) for strictly medical reasons. Specialists like Dr Hong Ju at Yonseisarangmoa Hospital use this chromosomal analysis. It mainly helps prevent severe sex-linked hereditary disorders in offspring.
Bookimed Expert Insight: While elective selection is banned, South Korean clinics excel at using PGT for aneuploidy screening. Specialists like Dr Hong Jung Lee use this to check embryo viability for women aged 40+. This improves success rates for patients even when gender disclosure remains legally restricted.
Patient Consensus: South Korea is not an option for social gender selection because laws are very strict. Couples often choose this location for high-quality medical IVF instead. PGT costs about A$400 per embryo to check for chromosomal health.